{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T01:18:25Z","timestamp":1784855905145,"version":"3.55.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","seminarsinnephrology.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.semnephrol.2016.05.002","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T06:16:06Z","timestamp":1469686566000},"page":"252-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Disorders of Iron Metabolism and Anemia in Chronic Kidney Disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Bhupesh","family":"Panwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando M.","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2016.05.002_bib1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1182\/blood-2003-03-0672","article-title":"Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation","volume":"102","author":"Ganz","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib2","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib3","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1073\/pnas.0409409102","article-title":"Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin","volume":"102","author":"Knutson","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5414\/CN107018","article-title":"Hepcidin and disordered mineral metabolism in chronic kidney disease","volume":"76","author":"Carvalho","year":"2011","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib5","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/ajh.20657","article-title":"Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis","volume":"81","author":"Malyszko","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib6","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/ki.2009.21","article-title":"Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease","volume":"75","author":"Ashby","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib7","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2215\/CJN.05931108","article-title":"Hepcidin\u2014a potential novel biomarker for iron status in chronic kidney disease","volume":"4","author":"Zaritsky","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib8","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.ajkd.2009.12.030","article-title":"Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD","volume":"55","author":"Babitt","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib9","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2011111078","article-title":"Mechanisms of anemia in CKD","volume":"23","author":"Babitt","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1681\/ASN.2013040355","article-title":"Suppression of iron-regulatory hepcidin by vitamin D","volume":"25","author":"Bacchetta","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib11","first-page":"1","article-title":"The effect of vitamin D3 on hepcidin and IL-8 expression in monocytes","volume":"2","author":"Bell","year":"2013","journal-title":"J Hematol"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib12","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1681\/ASN.2007010068","article-title":"How fibroblast growth factor 23 works","volume":"18","author":"Liu","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib13","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/jbmr.1923","article-title":"Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women","volume":"28","author":"Wolf","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/01.mnh.0000447020.74593.6f","article-title":"Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease","volume":"23","author":"Wolf","year":"2014","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib15","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0002-9343(68)90069-7","article-title":"Body iron excretion in man: a collaborative study","volume":"45","author":"Green","year":"1968","journal-title":"Am J Med"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/713609332","article-title":"Molecular mechanisms and regulation of iron transport","volume":"40","author":"Chung","year":"2003","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib17","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1006\/bcmd.2002.0574","article-title":"Molecular and functional roles of duodenal cytochrome B (Dcytb) in iron metabolism","volume":"29","author":"Latunde-Dada","year":"2002","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib18","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S1357-2725(99)00065-5","article-title":"The iron transporter DMT1","volume":"31","author":"Andrews","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib19","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1182\/blood-2005-02-0716","article-title":"Cybrd1 (duodenal cytochrome b) is not necessary for dietary iron absorption in mice","volume":"106","author":"Gunshin","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib20","doi-asserted-by":"crossref","first-page":"19906","DOI":"10.1074\/jbc.M000713200","article-title":"A novel mammalian iron-regulated protein involved in intracellular iron metabolism","volume":"275","author":"Abboud","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cmet.2005.01.003","article-title":"The iron exporter ferroportin\/Slc40a1 is essential for iron homeostasis","volume":"1","author":"Donovan","year":"2005","journal-title":"Cell Metab"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/5979","article-title":"Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse","volume":"21","author":"Vulpe","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cmet.2005.10.003","article-title":"Unexpected role of ceruloplasmin in intestinal iron absorption","volume":"2","author":"Cherukuri","year":"2005","journal-title":"Cell Metab"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0065-3233(08)60288-0","article-title":"Proteins of iron storage and transport","volume":"40","author":"Crichton","year":"1990","journal-title":"Adv Protein Chem"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib25","first-page":"1216","article-title":"Iron transport in the blood","volume":"63","author":"Fletcher","year":"1970","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib26","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.3945\/jn.108.102905","article-title":"Hepcidin decreases iron transporter expression in vivo in mouse duodenum and spleen and in vitro in THP-1 macrophages and intestinal Caco-2 cells","volume":"139","author":"Chung","year":"2009","journal-title":"J Nutr"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib27","doi-asserted-by":"crossref","first-page":"20826","DOI":"10.1074\/jbc.274.30.20826","article-title":"Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family","volume":"274","author":"Kawabata","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0092-8674(04)00343-5","article-title":"Balancing acts: molecular control of mammalian iron metabolism","volume":"117","author":"Hentze","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0005-2728(96)00022-9","article-title":"The ferritins: molecular properties, iron storage function and cellular regulation","volume":"1275","author":"Harrison","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib30","first-page":"193","article-title":"Hemosiderin: nature, formation, and significance","volume":"22","author":"Wixom","year":"1980","journal-title":"Int Rev Exp Pathol"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib31","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1074\/jbc.M008922200","article-title":"Hepcidin, a urinary antimicrobial peptide synthesized in the liver","volume":"276","author":"Park","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib32","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood-2005-04-1766","article-title":"Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs","volume":"106","author":"Rivera","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng1053","article-title":"Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis","volume":"33","author":"Roetto","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib34","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ng.335","article-title":"BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism","volume":"41","author":"Andriopoulos","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib35","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ng.320","article-title":"Lack of the bone morphogenetic protein BMP6 induces massive iron overload","volume":"41","author":"Meynard","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib36","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1182\/blood-2011-03-339952","article-title":"Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice","volume":"118","author":"Steinbicker","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib37","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cmet.2005.10.010","article-title":"A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression","volume":"2","author":"Wang","year":"2005","journal-title":"Cell Metab"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib38","doi-asserted-by":"crossref","first-page":"16416","DOI":"10.1074\/jbc.M110.109488","article-title":"The role of hepatocyte hemojuvelin in the regulation of bone morphogenic protein-6 and hepcidin expression in vivo","volume":"285","author":"Zhang","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib39","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng1777","article-title":"Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression","volume":"38","author":"Babitt","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/ng1274","article-title":"Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis","volume":"36","author":"Papanikolaou","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib41","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.24359","article-title":"Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)-SMAD signaling pathway in mice","volume":"54","author":"Corradini","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib42","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.24178","article-title":"Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice","volume":"53","author":"Ramos","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib43","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1182\/blood-2004-06-2477","article-title":"Diferric transferrin regulates transferrin receptor 2 protein stability","volume":"104","author":"Johnson","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib44","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1091\/mbc.E06-09-0798","article-title":"Transferrin receptor 2: evidence for ligand-induced stabilization and redirection to a recycling pathway","volume":"18","author":"Johnson","year":"2007","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib45","doi-asserted-by":"crossref","first-page":"G1397","DOI":"10.1152\/ajpgi.00020.2012","article-title":"Ferritin upregulates hepatic expression of bone morphogenetic protein 6 and hepcidin in mice","volume":"302","author":"Feng","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib46","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"Nemeth","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib47","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1172\/JCI0215686","article-title":"The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation","volume":"110","author":"Nicolas","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib48","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1182\/blood-2012-02-411470","article-title":"Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1\/5\/8 signaling","volume":"120","author":"Besson-Fournier","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib49","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4161\/cc.7.1.5145","article-title":"Role of the hypoxia inducible factors HIF in iron metabolism","volume":"7","author":"Peyssonnaux","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib50","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A Trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib51","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1681\/ASN.2007050606","article-title":"Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin","volume":"19","author":"Kapoian","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib52","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1681\/ASN.2006091034","article-title":"Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients\u2019 Response to IV Iron with Elevated Ferritin (DRIVE) study","volume":"18","author":"Coyne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib53","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib54","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"Normalization of hemoglobin level in patients with chronic kidney disease and anemia","volume":"355","author":"Dr\u00fceke","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib55","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1182\/blood-2013-08-522466","article-title":"Anti-hepcidin therapy for iron-restricted anemias","volume":"122","author":"Nemeth","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib56","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1182\/blood-2013-06-505792","article-title":"A fully human anti-hepcidin antibody modulates iron metabolism in both mice and nonhuman primates","volume":"122","author":"Cooke","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib57","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2009-09-245977","article-title":"Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia","volume":"115","author":"Sasu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib58","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood-2008-02-139915","article-title":"Immunoassay for human serum hepcidin","volume":"112","author":"Ganz","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib59","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1159\/000312381","article-title":"Determinants of hepcidin in patients on maintenance hemodialysis: role of inflammation","volume":"31","author":"Kuragano","year":"2010","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib60","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/ndt\/gfp546","article-title":"Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate","volume":"25","author":"Peters","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib61","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/ndt\/gfr431","article-title":"Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study","volume":"27","author":"Uehata","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib62","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/ajh.23110","article-title":"Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation","volume":"87","author":"Sun","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib63","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib64","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000081023","article-title":"Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study","volume":"24","author":"Gonzalez","year":"2004","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib65","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000202632","article-title":"25-hydroxyvitamin D deficiency and inflammation and their association with hemoglobin levels in chronic kidney disease","volume":"30","author":"Kendrick","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib66","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ki.2009.551","article-title":"Vitamin D deficiency and anemia in early chronic kidney disease","volume":"77","author":"Patel","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib67","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1182\/blood-2010-09-309708","article-title":"Prevalence of 25-hydroxyvitamin D deficiency in subgroups of elderly persons with anemia: association with anemia of inflammation","volume":"117","author":"Perlstein","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib68","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00392-011-0312-5","article-title":"Vitamin D deficiency is an independent predictor of anemia in end-stage heart failure","volume":"100","author":"Zittermann","year":"2011","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib69","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0301-472X(02)00789-0","article-title":"Novel role of 1,25(OH)(2)D(3) in induction of erythroid progenitor cell proliferation","volume":"30","author":"Alon","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib70","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1681\/ASN.2013040355","article-title":"Suppression of iron-regulatory hepcidin by vitamin D","volume":"25","author":"Bacchetta","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib71","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.jcte.2014.01.003","article-title":"The role of vitamin D in regulating the iron-hepcidin-ferroportin axis in monocytes","volume":"1","author":"Zughaier","year":"2014","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib72","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib73","doi-asserted-by":"crossref","first-page":"E1146","DOI":"10.1073\/pnas.1110905108","article-title":"Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice","volume":"108","author":"Farrow","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib74","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jbmr.2049","article-title":"Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice","volume":"29","author":"Clinkenbeard","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib75","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.bone.2012.03.010","article-title":"Iron status and fibroblast growth factor-23 in Gambian children","volume":"50","author":"Braithwaite","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib76","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1210\/jc.2009-1603","article-title":"Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active","volume":"95","author":"Shimada","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib77","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1210\/jc.2012-1811","article-title":"Biological variability of plasma intact and C-terminal FGF23 measurements","volume":"97","author":"Smith","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib78","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Guti\u00e9rrez","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib79","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Guti\u00e9rrez","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib80","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib81","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2010121224","article-title":"FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis","volume":"22","author":"Kendrick","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib82","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ki.2012.327","article-title":"Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community","volume":"83","author":"\u00c4rnl\u00f6v","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib83","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2016.05.002_bib84","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929516300316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929516300316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T20:47:23Z","timestamp":1568234843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929516300316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":84,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0270929516300316"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2016.05.002","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disorders of Iron Metabolism and Anemia in Chronic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2016.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}